Unintended Effects of HPV and Shingles Vaccines - Dr. Kevin Folta
Talking Biotech with Dr. Kevin FoltaShow Notes
Anti-vaccination activists, including the US Health and Human Services Secretary, decry the risk of vaccination. In two recently developed vaccines the emerging story is that there is risk in not being vaccinated. Analysis of large data sets shows that over the last 20 years, those vaccinated with the HPV vaccine have a lower incidence of cervical, penile and anal cancers, as they should. But they also show lower incidence of other cancers as well, such as lung, blood and nervous system cancers. The shingles vaccines seem to have protective effects against dementia, heart disease and stroke. All of thse findings suggest that broader vaccination may have public health benefit. More importantly, these may be strategies against vaccine hesitancy, as families don't remember the sourge of polio and measles, but they likely know someone with cancer or dementia. These findings could be a way to nucleate a shift in vaccine perception among evidence deniers. HPV and Other Cancers: https://www.sciencedirect.com/science/article/pii/S1043661825002762 Shingles vaccine and dementia: https://www.nature.com/articles/s41586-025-08800-x Shingles vaccine and cardiovascular disease: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf440/8229580 Singles vaccine and cardiovascular disease: https://academic.oup.com/eurheartj/article/46/30/2991/8124786
More from Talking Biotech with Dr. Kevin Folta
In this episode, Kevin Folta interviews Brigitte Weston, the director of product development at Gates Ag One, about their mission to accelerate crop technology development for smallholder farmers in Africa and South Asia. They discuss the organization's approach to innovation, regulatory challenges, and how they foster public-private partnerships to improve food security.
Oncolytic viruses may offer a new way to tackle solid tumors by targeting cancer cells and activating the immune system. Dr. Eric Poma explains how Calidi Biotherapeutics is engineering a vaccinia-based virus to evade immune clearance, reach tumors, and deliver an immune-stimulating payload. He and Kevin Folta discuss the approach’s potential for cancers such as lung cancer, melanoma, renal cancer, and head and neck cancers.
This episode explores the fascinating history and science behind GLP1 receptor agonists, their development from animal venom to life-changing diabetes and obesity treatments, and the importance of basic research in medical breakthroughs.
In this episode, Dr. Alexia Groff discusses her groundbreaking research on expressing mammalian myoglobin in plants using chloroplast transformation. We explore the implications for food production, biosecurity, and future applications in meat substitutes and nutritional enhancement. Chloroplast inheritance reduces gene flow risk, enhancing biosafety. Heterologous expression in plants can produce functional animal proteins.
This episode explores the cutting-edge advancements in ALS diagnostics and treatment, highlighting how AI and digital health are transforming patient care and research. Guest Indo Navar shares her journey from Silicon Valley entrepreneurship to pioneering innovative solutions for ALS and other neurodegenerative diseases.